Noninvasive assessment of portal hypertension in patients with cirrhosis

Hepatology

Volumn 53, Issue 2, 2011, Pages 683-694

  Thabut, Dominique ^a,b   Moreau, Richard ^a,c,d   Lebrec, Didier ^a,c,d  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BEAUJON HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ELASTOGRAPHY; ESOPHAGUS VARICES; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; SCREENING TEST; VASCULAR RESISTANCE; VENOUS PRESSURE;

BIOLOGICAL MARKERS; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; SEVERITY OF ILLNESS INDEX; VASCULAR RESISTANCE;

EID: 79251527202     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24129     Document Type: Review

References (74)

1. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-176.
2. Braillon A, Calès P, Valla D, Gaudy D, Geoffroy P, Lebrec D. Influence of the degree of liver failure on systemic and splanchnic hemodynamics and on response to propranolol in patients with cirrhosis. Gut 1986; 27: 1204-1209.
3. Krogsgaard K, Gluud C, Henriksen JH, Christoffersen P. Correlation between liver morphology and portal pressure in alcoholic liver disease. HEPATOLOGY 1984; 4: 699-703.
4. Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G. Histological-hemodynamic correlation in cirrhosis. A histological classification of the severity of cirrhosis. J Hepatol 2006; 44: 111-117.
5. Calvaruso V, Burroughs AK, Standish R, Manousou P, Grillo F, Leandro G, et al. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. HEPATOLOGY 2009; 49: 1236-1244.
6. Reynolds TB, Geller HM, Kuzma OT, Redeker AG. Spontaneous decrease in portal pressure with clinical improvement in cirrhosis. N Engl J Med 1960; 263: 734-739.
7. Lebrec D, Sogni P, Vilgrain V. Evaluation of patients with portal hypertension. Clin Gastroenterol 1997; 11: 221-241.
8. Gadano A, Hadengue A, Vachiery F, Moreau R, Sogni P, Soupison T, et al. Relationship between hepatic blood flow, liver tests, haemodynamic values and clinical characteristics in patients with chronic liver disease. J Gastroenterol Hepatol 1997; 12: 167-171.
9. Boyer TD, Triger DR, Horisawa M, Redeker AG, Reynolds TB. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology 1977; 72: 584-589.
10. Valla D, Bercoff E, Menu Y, Lebrec D. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis. Gastroenterology 1984; 86: 1400-1403.
11. Lin HC, Tsai YT, Chang TT, Lay CS, Lee SD, Lo KJ. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatic B-related cirrhosis. J Hepatol 1989; 9: 326-330.
12. Sarin SK, Sethi KK, Nanda R. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis and non-cirrhotic portal fibrosis. Gut 1987; 28: 260-266.
13. Lebrec D, de Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980; 79: 1139-1144.
14. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. HEPATOLOGY 1985; 5: 419-424.
15. Monescillo A, Martinez-Lagares F, Ruiz-del-!Arbol L, Sierra A, Guevara C, Jimenez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. HEPATOLOGY 2004; 40: 793-801.
16. Blanchet L, Lebrec D. Changes in splanchnic blood flow in portal hypertensive rats. Eur J Clin Invest 1982; 12: 327-330.
17. Valla D, Poynard T, Bercoff E, Bataille C, Goldfarb G, Lebrec D. Systemic circulatory syndrome in patients with cirrhosis. Relationship with hepatocellular failure and portal hypertension. Gastroenterol Clin Biol 1984; 8: 321-324.
18. Friman L. Portal pressure correlated to visceral circulation times. Acta Radiol Diagn 1979; 20: 737-752.
19. Genovesi S, Prata DM, Pozzi M, Ratti L, Milanese M, Vincenti A, et al. Baroreceptor sensitivity and baroreceptor effectiveness index in cirrhosis: the relevance of hepatic venous pressure gradient. Liver Int 2010; 30: 232-239.
20. Taourel P, Blanc P, Dauzat M, Chabre M, Pradel J, Gallix B, et al. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. HEPATOLOGY 1999; 28: 932-936.
21. Choi YJ, Baik SK, Park DH, Kim MY, Kim HS, Lee DK, et al. Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. J Gastroenterol Hepatol 2003; 18: 424-429.
22. Rockey DC. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis 2006; 10: 459-479.
23. Hartleb M, Kirstetter P, Moreau R, Soupison T, Pussard E, Hadengue A, et al. Relations entre les concentrations plasmatiques d'endothéline et la sévérité de la cirrhose. Gastroentérol Clin Biol 1994; 18: 407-412.
24. Abdelmoneim SS, Talwalkar J, Sethi S, Kamath P, Fathalla MMF, Kipp BR, et al. A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension. Liver Int 2009; 29: 191-196.
25. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218.
26. Gressner AM, Tittor W, Negwer A, Pick-Kober KH. Serum concentration of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases. Clin Chim Acta 1986; 161: 249-258.
27. Mal F, Hartmann DJ, Trinchet JC, Lacombe F, Ville G, Beaugrand M. Serum laminin and portal pressure in alcoholic cirrhosis. A study of 39 patients. Gastroenterol Clin Biol 1988; 12: 841-844.
28. Kondo M, Miszputen SJ, Leite-Mor MM, Parise ER. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels. Hepatogastroenterology 1995; 42: 542-545.
29. Kropf J, Gressner AM, Tittor W. Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum. Clin Chem 1991; 37: 30-35.
30. Gressner AM, Tittor W, Kropf J. Evaluation of serum aminoterminal procollagen type III propeptide as an index of portal hypertension and esophageal varices in chronic liver diseases. Clin Chim Acta 1988; 174: 163-170.
31. Thabut D, Imbert-Bismut F, Cazals-Hatem D, Messous D, Muntenaus M, Valla DC, et al. Relationship between the FibroTest and portal hypertension in patients with liver disease. Aliment Pharmacol Ther 2007; 26: 359-368.
32. Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, et al. A novel panel of blood markers to assess the degree of liver fibrosis. HEPATOLOGY 2005; 42: 1373-1381.
33. Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, et al. An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. PLoS One 2008; 3: e2573.
34. Friedrich-Rust M, Ong MF, Martens SJ, Sarrazin C, Bojunga J, Zeuzen S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-974.
35. Castera L, Forms X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-847.
36. Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13, 369 examinations. HEPATOLOGY 2010; 51: 828-835.
37. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. HEPATOLOGY 2007; 45: 1290-1297.
38. Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008; 27: 1261-1268.
39. Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, et al. Liver stiffness measurement as predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther 2008; 28: 1102-1110.
40. Rudler M, Cluzel P, Massard J, Varaut A, Lebray P, Auguste M, et al. Transient elastography (FibroScan) and hepatic venous pressure gradient measurement in patients with cirrhosis and gastrointestinal haemorrhage related to portal hypertension [Abstract]. HEPATOLOGY 2008; 48( Suppl): 324A.
41. Carrion JA, Navasa M, Bosch J, Bruguera, Gilabert R, Forms X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006; 12: 1791-1798.
42. Samonakis DN, Cholongitas E, Thalheimer U, Kalambokis G, Quaglia AP, Patch D, et al. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis. Liver Transpl 2007; 13: 1305-1311.
43. Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007; 5: 1207-1213.
44. Kravetz D, Bildozola M, Argonz J, Romero G, Korula J, Munoz A, et al. Patients with ascites have higher variceal pressure and wall tension than patients without ascites. Am J Gastroenterol 2000; 95: 1770-1775.
45. Pilette C, Oberti F, Aubé C, Rousselet MC, Bedossa P, Gallois Y, et al. Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol 1999; 31: 867-873.
46. Sarwar S, Khan AA, Butt AK, Shafquat F, Malik K, Ahmad I, et al. Non-endoscopic prediction of presence of esophageal varices in cirrhosis. J Coll Physicians Surg Pak 2005; 15: 528-531.
47. Simpson KJ, Finlayson NDC. Clinical evaluation of liver disease. Clin Gastroenterol 1995; 9: 639-659.
48. Hervé P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998; 11: 1153-1166.
49. de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008; 49: 520-527.
50. Thabut D, Moreau R, Lebrec D. Screening for esophageal varices: endoscopy, other tools, or endoscopy and other tools? HEPATOLOGY 2008; 47: 1434-1436.
51. Thabut D, Trabut JB, Massard J, Rudler M, Muntenau M, Messous D, et al. Non-invasive diagnosis of large oesophageal varices with Fibro Test in patients with cirrhosis: a preliminary retrospective study. Liver Int 2006; 26: 271-278.
52. Kazemi F, Kettaneh A, N'kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 230-235.
53. Castera L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009; 50: 59-68.
54. Kim YJ, Raman SS, Yu NC, To'o KJ, Jutabha R, Lu DS. Esophageal varices in cirrhotic patients: evaluation with liver CT. AJR Am J Roentgenol 2007; 188: 139-144.
55. Kim SH, Kim YJ, Lee JM, Choi KD, Chung YJ, Han JK, et al. Esophageal varices in patients with cirrhosis: multidetector CT esophagography-comparison with endoscopy. Radiology 2007; 242: 759-768.
56. Perri R, Chioream MV, Fidler JL, Flercher JG, Talwalkar JA, Stadheim L, et al. A prospective evaluation of computerized tomographic scanning as a screening modality for esophageal varices. HEPATOLOGY 2008; 47: 1587-1594.
57. Eisen G, Eliakim R, Zaman A, Schwartz J, Faigel D, Rondonotti E, et al. The accuracy of PillCam ESO capsule endoscopy versus conventional upper endoscopy for the diagnosis of oesophageal varices: a prospective three-center pilot study. Endoscopy 2006; 38: 31-35.
58. Lapalus MG, Dumortier J, Fumex F, Roman S, Lot M, Prost B, et al. Oesophageal capsule endoscopy versus oesophagogastroduodenoscopy for evaluating portal hypertension. A prospective comparative study of performance and tolerance. Endoscopy 2006; 38: 36-41.
59. Pena LR, Cox T, Koch AG, Bosch A. Study comparing oesophageal capsule endoscopy versus EGD in the detection of varices. Dig Liver Dis 2008; 40: 216-223.
60. de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, et al. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. HEPATOLOGY 2008; 47: 1595-1603.
61. Lapalus MG, Ben Soussan E, Gaudric M, Saurin JC, D'Halluin PN, Favre O, et al. Esophageal capsule endoscopy vs. EGD for the evaluation of portal hypertension: a French prospective multicenter comparative study. Am J Gastroenterol 104: 1112-1118.
62. Staritz M, Poralla T, Meyer zum Büschenfelde KH. Intravascular oesophageal variceal (IOVP) assessed by endoscopic fine needle puncture under basal conditions, Vasalva's manoeuvre and after glyceryltrinitrate application. Gut 1985; 26: 525-530.
63. Bosch J, Bordas JM, Rigau J, Viola C, Mastai R, Kravetz D, et al. Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy. HEPATOLOGY 1986; 6: 667-672.
64. Nevens F, Sprengers D, Feu F, Bosch J, Fevery J. Measurement of variceal pressure with an endoscopic pressure sensitive gauge: validation and effect of propranolol therapy in chronic conditions. J Hepatol 1996; 24: 66-73.
65. Feu F, Bordas JM, Luca A, Garcia-Pagan JC, Escorsell A, Bosch J, et al. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. HEPATOLOGY 1993; 18: 1082-1089.
66. Nevens F, Bustami R, Scheys I, Lessaffre E, Fevery J. Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients. HEPATOLOGY 1998; 27: 15-19.
67. Talwalkar JA, Yin M, Venkatesh S, Rossman PJ, Grimm RC, Manduca A, et al. Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol 2009; 193: 122-127.
68. Bolondi L, Gandolfi L, Ariente V, Caletti GC, Corcionni E, Gasbarrini G, et al. Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology 1982; 142: 167-172.
69. Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Gatta A. Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-Doppler. Ultrasound Med Biol 2001; 27: 901-907.
70. Vilgrain V, Lebrec D, Menu Y, Scherrer A, Nahum H. Comparison between ultrasonographic signs and the degree of portal hypertension in patients with cirrhosis. Gastrointest Radiol 1990; 15: 218-222.
71. Vizzutti F, Arena U, Rega L, Romanelli GR, Colagrande S, Cuofano S, et al. Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease. Liver Int 2007; 27: 1379-1388.
72. Kim MY, Baik SK, Park DH, Lim DW, Kim JW, Kim HS, et al. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective non randomized study. Liver Int 2007; 27: 1103-1110.
73. Van de Steenkiste C, Staelens S, Deleye S, de Vos F, Vandenberghe S, Geerts A, et al. Measurement of porto-systemic shunting in mice by novel three-dimensional micro-single photon emission computed tomography imaging enabling longitudinal follow-up. Liver Int 2010; 30: 1211-1220.
74. Cowan ML, Rahman TM, Krishna S. Proteomic approaches in the search for biomarkers of liver fibrosis. Trends Mol Med 2010; 16: 171-183.